Variant report
Variant | esv3438653 |
---|---|
Chromosome Location | chr7:138333736-138336496 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:81)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr7:138334319-138334545 | A549 | lung: | n/a | n/a |
2 | CEBPB | chr7:138334329-138334593 | HepG2 | liver: | n/a | n/a |
3 | CEBPB | chr7:138334170-138334642 | Hela-S3 | cervix: | n/a | n/a |
4 | CEBPB | chr7:138334437-138334529 | K562 | blood: | n/a | n/a |
5 | CTCF | chr7:138333840-138333990 | A549 | lung: | n/a | n/a |
6 | CTCF | chr7:138333609-138333901 | H1-hESC | embryonic stem cell: | n/a | chr7:138333712-138333725 chr7:138333709-138333727 |
7 | CTCF | chr7:138333762-138333886 | GM12878 | blood: | n/a | n/a |
8 | CTCF | chr7:138333612-138333948 | K562 | blood: | n/a | chr7:138333712-138333725 chr7:138333709-138333727 |
9 | CTCF | chr7:138333696-138333874 | HepG2 | liver: | n/a | chr7:138333712-138333725 chr7:138333709-138333727 |
10 | CTCF | chr7:138333800-138333950 | NB4 | blood: | n/a | n/a |
11 | CTCF | chr7:138333680-138333830 | SK-N-SH_RA | brain: | n/a | chr7:138333712-138333725 chr7:138333709-138333727 |
12 | CTCF | chr7:138333720-138333870 | HEK293 | kidney: | n/a | n/a |
13 | CTCF | chr7:138333720-138333870 | GM06990 | blood: | n/a | n/a |
14 | CTCF | chr7:138333820-138333970 | GM12872 | blood: | n/a | n/a |
15 | CTCF | chr7:138333840-138333990 | HRPEpiC | eye: | n/a | n/a |
16 | CTCF | chr7:138333740-138333890 | GM12873 | blood: | n/a | n/a |
17 | CTCF | chr7:138333787-138333861 | HepG2 | liver: | n/a | n/a |
18 | CTCF | chr7:138333740-138333890 | HRPEpiC | eye: | n/a | n/a |
19 | CTCF | chr7:138333540-138334058 | K562 | blood: | n/a | chr7:138333712-138333725 chr7:138333709-138333727 |
20 | CTCF | chr7:138333720-138333870 | BE2_C | brain: | n/a | n/a |
21 | CTCF | chr7:138333683-138333919 | K562 | blood: | n/a | chr7:138333712-138333725 chr7:138333709-138333727 |
22 | CTCF | chr7:138333644-138333901 | H1-hESC | embryonic stem cell: | n/a | chr7:138333712-138333725 chr7:138333709-138333727 |
23 | CTCF | chr7:138333795-138333869 | GM19240 | blood: | n/a | n/a |
24 | CTCF | chr7:138333760-138333910 | GM12872 | blood: | n/a | n/a |
25 | CTCF | chr7:138333700-138333850 | K562 | blood: | n/a | chr7:138333712-138333725 chr7:138333709-138333727 |
26 | CTCF | chr7:138333700-138333850 | MCF-7 | breast: | n/a | chr7:138333712-138333725 chr7:138333709-138333727 |
27 | CTCF | chr7:138333720-138333906 | K562 | blood: | n/a | n/a |
28 | CTCF | chr7:138333779-138333830 | GM19239 | blood: | n/a | n/a |
29 | CTCF | chr7:138333720-138333870 | HepG2 | liver: | n/a | n/a |
30 | CTCF | chr7:138333749-138333849 | GM12891 | blood: | n/a | n/a |
31 | CTCF | chr7:138333700-138333850 | BE2_C | brain: | n/a | chr7:138333712-138333725 chr7:138333709-138333727 |
32 | CTCF | chr7:138333771-138333808 | GM19238 | blood: | n/a | n/a |
33 | CTCF | chr7:138333648-138333986 | K562 | blood: | n/a | chr7:138333712-138333725 chr7:138333709-138333727 |
34 | CTCF | chr7:138333720-138333870 | WERI-Rb-1 | eye: | n/a | n/a |
35 | CTCF | chr7:138333699-138333918 | H1-hESC | embryonic stem cell: | n/a | chr7:138333712-138333725 chr7:138333709-138333727 |
36 | CTCF | chr7:138333720-138333870 | GM12875 | blood: | n/a | n/a |
37 | CTCF | chr7:138333740-138333876 | MCF-7 | breast: | n/a | n/a |
38 | CTCF | chr7:138333600-138333750 | GM12870 | blood: | n/a | chr7:138333712-138333725 chr7:138333709-138333727 |
39 | CTCF | chr7:138333800-138333950 | RPTEC | kidney: | n/a | n/a |
40 | CTCF | chr7:138333756-138333850 | MCF-7 | breast: | n/a | n/a |
41 | CTCF | chr7:138333735-138333853 | MCF-7 | breast: | n/a | n/a |
42 | CTCF | chr7:138333732-138333871 | Gliobla | brain: | n/a | n/a |
43 | CTCF | chr7:138333700-138333850 | A549 | lung: | n/a | chr7:138333712-138333725 chr7:138333709-138333727 |
44 | CTCF | chr7:138333740-138333891 | Hela-S3 | cervix: | n/a | n/a |
45 | CTCF | chr7:138333680-138333830 | K562 | blood: | n/a | chr7:138333712-138333725 chr7:138333709-138333727 |
46 | CTCF | chr7:138333696-138333910 | MCF-7 | breast: | n/a | chr7:138333712-138333725 chr7:138333709-138333727 |
47 | CTCF | chr7:138333680-138333830 | WERI-Rb-1 | eye: | n/a | chr7:138333712-138333725 chr7:138333709-138333727 |
48 | CTCF | chr7:138333660-138333810 | SK-N-SH_RA | brain: | n/a | chr7:138333712-138333725 chr7:138333709-138333727 |
49 | CTCF | chr7:138333700-138333850 | Hela-S3 | cervix: | n/a | chr7:138333712-138333725 chr7:138333709-138333727 |
50 | CTCF | chr7:138333761-138333843 | MCF-7 | breast: | n/a | n/a |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr7:138134483..138135008-chr7:138333376..138334299,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000234658 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs370485628 | chr7:138333738-138333739 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs374200485 | chr7:138333746-138333747 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs140188327 | chr7:138333769-138333770 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs143755972 | chr7:138333801-138333802 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs533968380 | chr7:138333811-138333812 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs151301864 | chr7:138333812-138333813 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs140498059 | chr7:138333818-138333819 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs150440671 | chr7:138333819-138333820 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs368282576 | chr7:138333820-138333821 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs370834594 | chr7:138333831-138333832 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs542951871 | chr7:138333859-138333860 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs145183727 | chr7:138333869-138333870 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs111769712 | chr7:138333880-138333881 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs374511170 | chr7:138333885-138333886 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs201629281 | chr7:138333916-138333917 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs1673176 | chr7:138333930-138333931 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs200732872 | chr7:138333932-138333933 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs568820242 | chr7:138333934-138333935 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs557426980 | chr7:138333935-138333936 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs78073388 | chr7:138333943-138333944 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs398006548 | chr7:138333944-138333945 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs113069397 | chr7:138333945-138333946 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs77393031 | chr7:138333946-138333947 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs527255950 | chr7:138333952-138333953 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs547047387 | chr7:138333954-138333955 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs77964394 | chr7:138333955-138333956 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs146366547 | chr7:138333991-138333992 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs549316017 | chr7:138333993-138333994 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs549593750 | chr7:138334010-138334011 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs201274309 | chr7:138334039-138334040 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs190732587 | chr7:138334064-138334065 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs575103016 | chr7:138334071-138334072 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs193037642 | chr7:138334095-138334096 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs538565607 | chr7:138334107-138334108 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs551832041 | chr7:138334164-138334165 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs567642866 | chr7:138334172-138334173 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs1659796 | chr7:138334187-138334188 | Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs534316483 | chr7:138334195-138334196 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs572409822 | chr7:138334196-138334197 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs536547151 | chr7:138334202-138334203 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs536294396 | chr7:138334205-138334206 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs185390739 | chr7:138334252-138334253 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs576167969 | chr7:138334262-138334263 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs189965998 | chr7:138334273-138334274 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs558735261 | chr7:138334284-138334285 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs142881368 | chr7:138334291-138334292 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs181392964 | chr7:138334297-138334298 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs560551510 | chr7:138334329-138334330 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs150635899 | chr7:138334382-138334383 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs576490979 | chr7:138334389-138334390 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Wilms tumour | 21544195 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Low-grade fibromyxoid sarcoma | 0 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 21264507 | CNVD |
Shwachman-Diamond syndrome | 22934832 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Cutaneous malignant melanoma | 17690212 | CNVD |
Leukemia | 17361228 | CNVD |
Breast cancer | 16461572 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Malignant melanoma | 17690212 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 16573809 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Melanoma | 19188590 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
abnormal development | 18461090 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Malignant melanoma | 17260012 | CNVD |
Coffin-Siris syndrome | 21572526 | CNVD |
Papillary thyroid carcinoma | 21436994 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Hodgkin''s lymphoma | 18179710 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Breast cancer | 16272173 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Stuttering | 21108403 | CNVD |
Breast cancer | 17603634 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Myelodysplastic syndrome | 17634407 | CNVD |
Acute myeloid leukemia | 17237825 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Bladder cancer | 21909424 | CNVD |
Cancer | 21129771 | CNVD |
Myelofibrosis | 22110671 | CNVD |
T-cell acute lymphoblastic leukemia | 20065082 | CNVD |
T-cell acute lymphoblastic leukemia | 16673021 | CNVD |
Cancer | 21183584 | CNVD |
Intracranial ependymoma | 16609018 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Developmental delay | 19490664 | CNVD |
Pancreatitis | 20877625 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Low-grade astrocytoma | 19016743 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Pilocytic astrocytoma | 18408760 | CNVD |
Idiopathic chronic pancreatitis | 19584086 | CNVD |
Pediatric low-grade astrocytoma | 19016743 | CNVD |
Acute lymphoblastic leukemia | 17315016 | CNVD |
Gastric cancer | 16891809 | CNVD |
Cancer | 17440070 | CNVD |
Astrocytoma | 18398503 | CNVD |
Melanoma | 19671679 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Breast cancer | 17133270 | CNVD |
Schizophrenia | 17646849 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:138330200-138333800 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
2 | chr7:138333600-138335200 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
3 | chr7:138334000-138334800 | Enhancers | Placenta | Placenta |